Taming Glioblastoma: Targeting Angiogenesis

This publication has 23 references indexed in Scilit:

• Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
  Journal of Clinical Oncology, 2007
• AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
  Cancer Cell, 2007
• Angiogenesis-independent tumor growth mediated by stem-like cancer cells
  Proceedings of the National Academy of Sciences, 2006
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationRole of oxygenation, angiopoietin-1, and matrix metalloproteinases
  Cancer Cell, 2004
• Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study
  Journal of Neurology, Neurosurgery & Psychiatry, 2004
• The Hallmarks of Cancer
  Cell, 2000
• Response and progression in recurrent malignant glioma
  Neuro-Oncology, 1999
• The use of PET in evaluating patients with primary brain tumours: is it useful?
  Journal of Neurology, Neurosurgery & Psychiatry, 1995
• Incidence and treatment of peripheral venous thrombosis in patients with glioma
  Annals of Neurology, 1983
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971